ParkerVision Reports $1.97 Million Net Loss in Q3 2025, No Revenue Generated

ParkerVision, Inc. reported significant financial challenges in its latest 10-Q filing for the third quarter of 2025, revealing a net loss of approximately $1.97 million for the three months ended September 30, 2025, compared to a net loss of $10.81 million for the same period in 2024. For the nine months ended September 30, 2025, the company incurred a net loss of $7.4 million, a decrease from $11.83 million in the prior year. Despite these reductions in losses, the company reported no revenue for both the three and nine months ended September 30, 2025, consistent with the previous year, highlighting ongoing difficulties in generating income from its patent enforcement and licensing activities.

The company’s financial position has deteriorated, with total current assets dropping to $1.15 million as of September 30, 2025, down from $5.05 million at the end of 2024. Cash and cash equivalents also fell sharply to $901,000 from $4.92 million. Current liabilities increased to $2.95 million, including $1.63 million in convertible debt due within the next twelve months. This situation raises substantial doubt about ParkerVision's ability to continue as a going concern, as indicated in the filing, particularly given its accumulated deficit of $455.58 million.

Operationally, ParkerVision has focused on its patent enforcement actions, which are ongoing against various technology companies for alleged infringement of its wireless technologies. The company has made significant investments in legal proceedings, which have contributed to a 170.4% increase in selling, general, and administrative expenses for the nine months ended September 30, 2025, compared to the same period in 2024. This increase includes a notable rise in share-based compensation, which accounted for $3.16 million in expenses, reflecting new awards and modifications to existing options.

In terms of strategic developments, ParkerVision filed a shelf registration statement in May 2025, allowing it to offer up to $25 million in common stock or warrants to fund future capital needs. The company has not yet utilized this shelf but aims to leverage it to address liquidity challenges. Additionally, the company has seen a decrease in its long-term liabilities, primarily due to the reclassification of convertible notes to current liabilities as they approach maturity. The company anticipates that these notes will either be converted into shares or have their maturity dates extended, although this is contingent on the holders' decisions.

Looking ahead, ParkerVision's ability to meet its liquidity needs remains uncertain. The company expects that proceeds from patent enforcement actions and technology licenses may not be sufficient to cover its working capital requirements over the next twelve months. Management has indicated that future success will depend on negotiating licensing agreements and controlling operating costs, as well as the behavior of convertible note holders. The company continues to invest in its patent licensing and enforcement program, but without significant revenue generation, its long-term viability is at risk.